Science and Research

GTTELESCOPE: A Study to Genetically Define Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

TELESCOPE is a community-based genetic screening study designed to identify people with Geographic Atrophy (GA), secondary to Age-related Macular Degeneration (AMD) who have a certain genetic profile.


In the study, a person’s genetic profile is determined through a process called “genotyping” using saliva samples provided by the potential participants.

Genotyping is a process whereby a person’s DNA is evaluated using biological tests to determine differences in their genetic makeup, when compared to other individuals. A certain genetic makeup might indicate a predisposition to a disease like dry AMD.

The results of the saliva test may qualify participants for enrolment into one of Gyroscope’s ongoing trials evaluating a gene therapy for GA.

Who can participate?

TELESCOPE eligibility includes those with GA due to AMD in one or both eyes, who have no history of wet AMD and are 55 years old or older.

The TELESCOPE study is currently enrolling participants in Australia.

For more information please visit www.gyroscopetx.com/clinical-trials/ or contact Principal Investigator Dr Zhichao Wu’s team on 03 9929 8388 or amd-studies@cera.org.au.

  • Principal Investigator
Associate Professor Zhichao Wu